Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 41 results.
User Information
Export Records
  1. 1.   Ca2+-Dependent Switch of Calmodulin Interaction Mode with Tandem IQ Motifs in the Scaffolding Protein IQGAP1
  2. Zhang,Mingzhen; Li, Zhigang; Jang,Hyunbum; Hedman, Andrew C.; Sacks, David B.; Nussinov,Ruth
  3. BIOCHEMISTRY. 2019, Dec 10; 58(49): 4903-4911.
  1. 2.   Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
  2. Ma, Lichun; Hernandez,Maria; Zhao,Yongmei; Mehta,Monika; Tran,Bao; Kelly,Michael; Rae,Zachary; Hernandez, Jonathan M; Davis, Jeremy L; Martin, Sean P; Kleiner, David E; Hewitt, Stephen M; Ylaya, Kris; Wood, Bradford J; Greten, Tim F; Wang, Xin Wei
  3. Cancer cell. 2019, Oct 14; 36(4): 418-430.
  1. 3.   Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort
  2. Yang, Baiyu; Petrick, Jessica L.; Thistle, Jake E.; Pinto,Ligia; Kemp,Troy; Gewirtz, Andrew T.; Waterboer, Tim; Fedirko, Veronika; Jenab, Mazda; Graubard, Barry I.; Weinstein, Stephanie J.; Albanes, Demetrius; McGlynn, Katherine A.
  3. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2019, Apr; 28(4): 807-813.
  1. 4.   The Bladder Tumor Suppressor Protein TERE1 (UBIAD1) Modulates Cell Cholesterol: Implications for Tumor Progression
  2. Fredericks, W. J.; McGarvey, T.; Wang, H. Y.; Lal, P.; Puthiyaveettil, R.; Tomaszewski, J.; Sepulveda, J.; Labelle, E.; Weiss, J. S.; Nickerson, M. L.; Kruth, H. S.; Brandt, W.; Wessjohann, L. A.; Malkowicz, S. B.
  3. DNA and Cell Biology. 2011, Nov; 30(11): 851-864.
  1. 5.   SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
  2. Kim, H. S.; Vassilopoulos, A.; Wang, R. H.; Lahusen, T.; Xiao, Z.; Xu, X. L.; Li, C. L.; Veenstra, T. D.; Li, B.; Yu, H. T.; Ji, J. F.; Wang, X. W.; Park, S. H.; Cha, Y. I.; Gius, D.; Deng, C. X.
  3. Cancer Cell. 2011, Oct; 20(4): 487-499.
  1. 6.   Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122
  2. Boutz, D. R.; Collins, P. J.; Suresh, U.; Lu, M. Z.; Ramirez, C. M.; Fernandez-Hernando, C.; Huang, Y. F.; Abreu, R. D.; Le, S. Y.; Shapiro, B. A.; Liu, A. M.; Luk, J. M.; Aldred, S. F.; Trinklein, N. D.; Marcotte, E. M.; Penalva, L. O. F.
  3. Journal of Biological Chemistry. 2011, May; 286(20): 18066-18078.
  1. 7.   A Common HLA-DPA1 Variant is a Major Determinant of Hepatitis B Virus Clearance in Han Chinese
  2. An, P.; Winkler, C.; Guan, L.; O'Brien, S. J.; Zeng, Z.; Consortium, H. B. V. S.
  3. Journal of Infectious Diseases. 2011, Apr; 203(7): 943-947.
  1. 8.   Coactivation of AKT and beta-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
  2. Stauffer, J. K.; Scarzello, A. J.; Andersen, J. B.; De Kluyver, R. L.; Back, T. C.; Weiss, J. M.; Thorgeirsson, S. S.; Wiltrout, R. H.
  3. Cancer Research. 2011, Apr; 71(7): 2718-2727.
  1. 9.   Strong Influence of Human Leukocyte Antigen (HLA)-DP Gene Variants on Development of Persistent Chronic Hepatitis B Virus Carriers in the Han Chinese Population
  2. Guo, X. C.; Zhang, Y.; Li, J.; Ma, J. C.; Wei, Z. L.; Tan, W. J.; O'Brien, S. J.
  3. Hepatology. 2011, Feb; 53(2): 422-428.
  1. 10.   Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations
  2. Yang, X. R.; Liang, X. Y.; Pfeiffer, R. M.; Wheeler, W.; Maeder, D.; Burdette, L.; Yeager, M.; Chanock, S.; Tucker, M. A.; Goldstein, A. M.
  3. Familial Cancer. 2010, Dec; 9(4): 625-633.
  1. 11.   Abnormal Placental Development and Early Embryonic Lethality in EpCAM-Null Mice
  2. Nagao, K.; Zhu, J. J.; Heneghan, M. B.; Hanson, J. C.; Morasso, M. I.; Tessarollo, L.; Mackem, S.; Udey, M. C.
  3. Plos One. 2009, Dec; 4(12): 9.
  1. 12.   In vitro and In vivo Radiosensitization with AZD6244 (ARRY-142886), an Inhibitor of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase 1/2 Kinase
  2. Chung, E. J.; Brown, A. P.; Asano, H.; Mandler, M.; Burgan, W. E.; Carter, D.; Camphausen, K.; Citrin, D.
  3. Clinical Cancer Research. 2009 15(9): 3050-3057.
  1. 13.   Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo
  2. Hanse, E. A.; Nelsen, C. J.; Goggin, M. M.; Anttila, C. K.; Mullany, L. K.; Berthet, C.; Kaldis, P.; Crary, G. S.; Kuriyama, R.; Albrecht, J. H.
  3. Cell Cycle. 2009 8(17): 2802-2809.
  1. 14.   Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver
  2. Inagaki, K.; Piao, C. C.; Kotchey, N. M.; Wu, X. L.; Nakai, H.
  3. Journal of Virology. 2008 82(19): 9513-9524.
  1. 15.   Effects of o-aminoazotoluene on liver regeneration and p53 activation in mice susceptible and resistant to hepatocarcinogenesis
  2. Timofeeva, O. A.; Eremeev, A. V.; Goloshchapov, A.; Kalashnikova, E.; Ilnitskaya, S.; Setkov, N. A.; Kobzev, V.; Buzard, G. S.; Filipenko, M. L.; Kaledin, V.; Merkulova, T. I.
  3. Toxicology. 2008 254(1-2): 91-96.
  1. 16.   Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome
  2. Truelove, A. L.; Oleksyk, T. K.; Shrestha, S.; Thio, C. L.; Goedert, J. J.; Donfield, S. M.; Kirk, G. D.; Thomas, D. L.; O'Brien, S. J.; Smith, M. W.
  3. International Journal of Immunogenetics. 2008 35(3): 255-264.
  1. 17.   A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population
  2. Zeng, Z.; Guan, L.; An, P.; Sun, S.; O'Brien, S. J.; Winkler, C. A.; Consortium, C. H. S.
  3. BMC Infectious Diseases. 2008 8(1): 1-9.
  1. 18.   Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000
  2. Tseng, F. C.; O'Brien, T. R.; Zhang, M.; Kral, A. H.; Ortiz-Conde, B. A.; Lorvick, J.; Busch, M. P.; Edlin, B. R.
  3. Hepatology. 2007, Sep; 46(3): 666-671.
  1. 19.   Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic
  2. Xie, Y. X.; Liu, J.; Benbrahim-Tallaa, L.; Ward, J. M.; Logsdon, D.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology. 2007, Jul; 236(1-2): 7-15.
  1. 20.   The role of electrophoresis in disease biomarker discovery
  2. Issaq, H. J.; Veenstra, T. D.
  3. Electrophoresis. 2007, Jun; 28(12): 1980-1988.
  1. 21.   Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism
  2. Liu, J.; Xie, Y. X.; Cooper, R.; Duchanne, D. M. K.; Tennant, R.; Diwan, B. A.; Waalkes, M. P.
  3. Toxicology and Applied Pharmacology. 2007, May; 220(3): 284-291.
  1. 22.   Hepatitis C and risk of lymphoma: Results of the European Multicenter Case-Control Study EPILYMPH
  2. Nieters, A.; Kallinowski, B.; Brennan, P.; Ott, M.; Maynadie, M.; Benavente, Y.; Foretova, L.; Cocco, P. L.; Staines, A.; Vornanen, M.; Whitby, D.; Boffetta, P.; Becker, N.; De Sanjose, S.
  3. Gastroenterology. 2006, Dec; 131(6): 1879-1886.
  1. 23.   Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer
  2. Jazii, F. R.; Najafi, Z.; Malekzadeh, R.; Conrads, T. P.; Ziaee, A. A.; Abnet, C.; Yazdznbod, M.; Karkhane, A. A.; Salekdeh, G. H.
  3. World Journal of Gastroenterology. 2006, Nov; 12(44): 7104-7112.
  1. 24.   Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses
  2. Waalkes, M. P.; Liu, J.; Kasprzak, K. S.; Diwan, B. A.
  3. International Journal of Cancer. 2006, JUL 1; 119(1): 28-32.
  1. 25.   Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver
  2. Liu, J.; Xie, Y. X.; Merrick, B. A.; Shen, J.; Ducharme, D. M. K.; Collins, J.; Diwan, B. A.; Logsdon, D.; Waalkes, M. P.
  3. Toxicology and Applied Pharmacology. 2006, Jun; 213(3): 216-223.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel